MedTrace Logo

Clinical Phenotype and Outcomes of Inpatients With COVID-19 and Diabetes

NCT04550403 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 757

Last updated 2022-02-17

No results posted yet for this study

Summary

Patients with diabetes have been listed as people at higher risk for severe illness from COVID-19. Moreover, the relationship between diabetes-related phenotypes and the severity of COVID-19 remains unknown. This observational study aims to to evaluate the risk of disease severity and mortality in association with diabetes in COVID-19 inpatients and identify the clinical and biological features associated with worse outcomes.

Conditions

Sponsors & Collaborators

  • Azienda Ospedaliero-Universitaria di Parma

    lead OTHER

Principal Investigators

  • Riccardo Bonadonna, MD, PhD · Azienda Ospedaliero-Universitaria di Parma

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-30
Primary Completion
2021-10-30
Completion
2021-12-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04550403 on ClinicalTrials.gov